| Revenue | 6,225.1b | 6,238.26b |
| Cost of sales | -5,614.83b | -5,577.87b |
| Gross profit | 610.26b | 660.39b |
| Marketing expenses | -62.76b | -49.69b |
| General administrative expenses | -163.41b | -112.74b |
| Research and development expenses | -10.24b | -8.02b |
| Other operating income | 298.5b | 193.67b |
| Other operating expenses | -30.02b | -61.49b |
| Operating profit | 642.34b | 622.12b |
| Income from investing activities | 15.92b | 15.15b |
| Expenses from investing activities | -8.44b | -22.98b |
| Share of investments' profit (loss) accounted by using the equity method | 6.24b | 3.31b |
| Operating profit before finance income (expenses) | 656.08b | 617.61b |
| Finance income | 153.11b | 139.05b |
| Finance expense | -380.5b | -353.42b |
| Monetary gain/(loss) | -16.17b | -30.49b |
| Profit before tax | 412.52b | 372.74b |
| Tax (expense) income | -20.46b | -190.15b |
| Current corporate tax (expense) income | -16.91b | -200.83b |
| Deferred tax (expense) income | -37.37b | -10.68b |
| Net profit (loss) for the period | 432.98b | 182.6b |
| Equity holders of the parent | 411.27b | 170.11b |
| Non-controlling interests | 21.71b | 12.48b |